secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2022-07-01T23:59:59+00:00
Accession:  0001213900-22-036699
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics receives Nasdaq extension to Dec 26, 2022 to meet $1 bid price rule
--------------------------------------------------------------------------------

- Received Nasdaq extension to regain compliance with minimum bid price, now deadline Dec 26, 2022.
- Original compliance period expired June 28, 2022; additional 180 days granted.
- No immediate effect on listing or trading of HOTH common stock on Nasdaq.
- If bid price does not close at $1.00+ for 10 consecutive business days by Dec 26, delisting may follow.
- Company may consider reverse stock split if needed to meet requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022036699/0001213900-22-036699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022036699/ea162355-8k_hoththerape.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-036699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer